Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.0800 (7.65%) ($12.0200 - $13.0800) on Mon. Mar. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.06% (three month average) | RSI | 42 | Latest Price | $13.0800(7.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -8.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(49%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -2.03% in a week (0% probabilities). VIXM(-37%) VXX(-36%) TLT(-11%) UNG(-7%) UUP(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.03% (StdDev 4.06%) | Hourly BBV | 0 () | Intraday Trend | 6.8% | | | |
|
1 - 5 Day Possible Target | $-4.25(-132.49%) | Resistance Level | $13.35 | 5 Day Moving Average | $11.8(10.85%) | 10 Day Moving Average | $12.63(3.56%) | 20 Day Moving Average | $13.35(-2.02%) | To recent high | -26.4% | To recent low | 17.6% | Market Cap | $972m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |